Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 28 2025
0mins
Source: Globenewswire
Company Announcement: Cocrystal Pharma, Inc. will participate in a fireside chat at the Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference on June 5, 2025, welcoming audience questions and offering one-on-one meetings for registered investors.
About Cocrystal Pharma: The company is focused on developing antiviral therapeutics targeting various viruses, utilizing advanced technologies and expertise to create innovative treatments.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
